Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Flow Cytometry | 73 | 2023 | 5975 | 5.790 |
Why?
|
Immunophenotyping | 18 | 2016 | 1866 | 1.060 |
Why?
|
Hematopoietic Stem Cells | 10 | 2015 | 3381 | 0.950 |
Why?
|
Lymphoma, T-Cell | 4 | 2018 | 299 | 0.750 |
Why?
|
Hematologic Neoplasms | 11 | 2020 | 1820 | 0.730 |
Why?
|
CD4-Positive T-Lymphocytes | 9 | 2013 | 4379 | 0.710 |
Why?
|
Bone Marrow Transplantation | 15 | 2017 | 2763 | 0.670 |
Why?
|
Blood Cells | 3 | 2014 | 309 | 0.590 |
Why?
|
Antigens, Surface | 7 | 2015 | 1663 | 0.580 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 222 | 0.540 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 2015 | 329 | 0.530 |
Why?
|
Plasma Cells | 3 | 2016 | 592 | 0.500 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2015 | 98 | 0.500 |
Why?
|
Blood Platelets | 5 | 2014 | 2506 | 0.490 |
Why?
|
Periodicals as Topic | 2 | 2017 | 1431 | 0.450 |
Why?
|
Kidney Transplantation | 25 | 2017 | 4246 | 0.450 |
Why?
|
Antigens, CD34 | 6 | 2011 | 657 | 0.440 |
Why?
|
Cytotoxicity, Immunologic | 5 | 2015 | 1368 | 0.440 |
Why?
|
Monocytes | 5 | 2012 | 2593 | 0.440 |
Why?
|
Transplantation Chimera | 12 | 2017 | 612 | 0.430 |
Why?
|
Gold Colloid | 1 | 2011 | 13 | 0.420 |
Why?
|
Stem Cells | 5 | 2015 | 3563 | 0.410 |
Why?
|
B-Lymphocytes | 7 | 2017 | 4664 | 0.400 |
Why?
|
Pancytopenia | 1 | 2012 | 104 | 0.390 |
Why?
|
Antigens, Neoplasm | 6 | 2018 | 1983 | 0.390 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 974 | 0.380 |
Why?
|
Leukocyte Count | 3 | 2012 | 1583 | 0.350 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2015 | 1820 | 0.350 |
Why?
|
Stem Cell Niche | 1 | 2012 | 342 | 0.340 |
Why?
|
Receptors, Antigen, T-Cell | 6 | 2022 | 2524 | 0.330 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2013 | 4438 | 0.320 |
Why?
|
Transplantation Conditioning | 13 | 2014 | 1597 | 0.320 |
Why?
|
Multiple Myeloma | 6 | 2016 | 5169 | 0.320 |
Why?
|
Lymphoma | 8 | 2022 | 1873 | 0.310 |
Why?
|
Antigens, CD | 12 | 2011 | 4024 | 0.310 |
Why?
|
Bone Marrow | 5 | 2014 | 2941 | 0.290 |
Why?
|
Antibodies, Monoclonal | 25 | 2010 | 9274 | 0.290 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1596 | 0.280 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2012 | 810 | 0.270 |
Why?
|
Transplantation Tolerance | 4 | 2017 | 617 | 0.270 |
Why?
|
CD4 Lymphocyte Count | 2 | 2011 | 2557 | 0.270 |
Why?
|
Graft Survival | 11 | 2017 | 3733 | 0.250 |
Why?
|
Mast Cells | 1 | 2011 | 1544 | 0.240 |
Why?
|
Hematopoietic Stem Cell Transplantation | 6 | 2016 | 5425 | 0.240 |
Why?
|
Bleomycin | 2 | 2004 | 499 | 0.230 |
Why?
|
T-Lymphocytes | 21 | 2020 | 10163 | 0.230 |
Why?
|
Burkitt Lymphoma | 3 | 2013 | 328 | 0.230 |
Why?
|
Immunotherapy, Adoptive | 3 | 2022 | 1255 | 0.230 |
Why?
|
Hematopoiesis | 4 | 2014 | 2066 | 0.220 |
Why?
|
Fluorescent Antibody Technique | 5 | 2011 | 2505 | 0.220 |
Why?
|
Antigens, CD20 | 7 | 2013 | 198 | 0.220 |
Why?
|
Humans | 128 | 2023 | 742088 | 0.210 |
Why?
|
Myelodysplastic Syndromes | 1 | 2012 | 1351 | 0.210 |
Why?
|
Anti-Mullerian Hormone | 6 | 2012 | 399 | 0.210 |
Why?
|
Cell Differentiation | 12 | 2015 | 11470 | 0.210 |
Why?
|
Antigens, CD19 | 4 | 2022 | 379 | 0.200 |
Why?
|
DNA, Neoplasm | 12 | 1996 | 1758 | 0.200 |
Why?
|
Immune Tolerance | 5 | 2017 | 2257 | 0.190 |
Why?
|
Immunization, Passive | 8 | 2003 | 625 | 0.190 |
Why?
|
Bone Marrow Cells | 5 | 2015 | 2513 | 0.190 |
Why?
|
Malaria, Falciparum | 1 | 2009 | 1071 | 0.190 |
Why?
|
Leukemia | 3 | 2011 | 1507 | 0.180 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2004 | 692 | 0.180 |
Why?
|
Killer Cells, Natural | 6 | 2018 | 2133 | 0.180 |
Why?
|
Pulmonary Fibrosis | 1 | 2004 | 526 | 0.180 |
Why?
|
Cell Adhesion Molecules | 7 | 2010 | 1599 | 0.180 |
Why?
|
Biomedical Research | 2 | 2019 | 3306 | 0.180 |
Why?
|
Interleukin-10 | 1 | 2004 | 1200 | 0.160 |
Why?
|
Cell Proliferation | 7 | 2018 | 10472 | 0.160 |
Why?
|
Transplantation, Homologous | 18 | 2014 | 4771 | 0.160 |
Why?
|
Staining and Labeling | 2 | 2012 | 1099 | 0.160 |
Why?
|
T-Lymphocyte Subsets | 2 | 2004 | 1837 | 0.150 |
Why?
|
Mycoplasma fermentans | 1 | 1997 | 9 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2013 | 987 | 0.150 |
Why?
|
Myometrium | 2 | 2009 | 181 | 0.150 |
Why?
|
Testicular Hormones | 4 | 2006 | 188 | 0.150 |
Why?
|
Cytochrome P-450 Enzyme System | 2 | 2014 | 419 | 0.150 |
Why?
|
Tonsillar Neoplasms | 1 | 2017 | 51 | 0.140 |
Why?
|
Cell Lineage | 4 | 2014 | 2504 | 0.140 |
Why?
|
Muromonab-CD3 | 2 | 1999 | 96 | 0.140 |
Why?
|
Palatine Tonsil | 1 | 2017 | 193 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2013 | 1434 | 0.140 |
Why?
|
Lectins | 2 | 2003 | 514 | 0.140 |
Why?
|
Cell Cycle | 6 | 2018 | 2964 | 0.130 |
Why?
|
Cobalt | 1 | 2016 | 158 | 0.130 |
Why?
|
Bacterial Adhesion | 1 | 1997 | 316 | 0.130 |
Why?
|
Orbital Pseudotumor | 1 | 2015 | 42 | 0.130 |
Why?
|
Microscopy, Fluorescence | 4 | 2014 | 2699 | 0.130 |
Why?
|
Lymphocyte Count | 3 | 2017 | 792 | 0.130 |
Why?
|
Dacryocystitis | 1 | 2015 | 69 | 0.130 |
Why?
|
Dendritic Cells | 6 | 2003 | 2723 | 0.130 |
Why?
|
Peroxidase | 1 | 1998 | 610 | 0.130 |
Why?
|
Animals | 48 | 2018 | 168561 | 0.130 |
Why?
|
Interleukin-2 | 10 | 2003 | 1887 | 0.130 |
Why?
|
Pneumonia | 2 | 2004 | 2117 | 0.130 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 4 | 1989 | 906 | 0.120 |
Why?
|
Antineoplastic Agents | 10 | 2016 | 13655 | 0.120 |
Why?
|
Graft Rejection | 16 | 2011 | 4393 | 0.120 |
Why?
|
Cell Separation | 7 | 2009 | 1749 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2022 | 895 | 0.120 |
Why?
|
Swine, Miniature | 1 | 2015 | 961 | 0.110 |
Why?
|
Cells, Cultured | 17 | 2015 | 19223 | 0.110 |
Why?
|
Glycoproteins | 5 | 2006 | 2260 | 0.110 |
Why?
|
Ovarian Neoplasms | 6 | 2012 | 4823 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2013 | 1377 | 0.110 |
Why?
|
Neoplastic Stem Cells | 2 | 2012 | 1376 | 0.110 |
Why?
|
Leukotriene B4 | 1 | 2014 | 293 | 0.110 |
Why?
|
Lymphocytes | 8 | 2004 | 2614 | 0.110 |
Why?
|
Mice | 30 | 2018 | 81045 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2012 | 11472 | 0.110 |
Why?
|
Stem Cell Factor | 1 | 2012 | 219 | 0.110 |
Why?
|
Teriparatide | 1 | 2014 | 225 | 0.100 |
Why?
|
Rare Diseases | 1 | 2017 | 554 | 0.100 |
Why?
|
Lymphoma, B-Cell | 1 | 2018 | 930 | 0.100 |
Why?
|
Bromodeoxyuridine | 4 | 2008 | 322 | 0.100 |
Why?
|
Lung | 6 | 2004 | 9826 | 0.100 |
Why?
|
Capillary Leak Syndrome | 1 | 2011 | 31 | 0.100 |
Why?
|
Kidney Failure, Chronic | 3 | 2010 | 2536 | 0.100 |
Why?
|
Fluorescent Dyes | 5 | 2012 | 1915 | 0.100 |
Why?
|
Leukocytosis | 1 | 2012 | 247 | 0.100 |
Why?
|
Lymphocyte Transfusion | 3 | 2008 | 235 | 0.100 |
Why?
|
Indicators and Reagents | 1 | 2011 | 462 | 0.100 |
Why?
|
Receptors, Peptide | 3 | 2007 | 272 | 0.090 |
Why?
|
Casein Kinase Ialpha | 1 | 2010 | 26 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2017 | 2986 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 2 | 2012 | 1625 | 0.090 |
Why?
|
Health Resources | 1 | 2016 | 911 | 0.090 |
Why?
|
Phycoerythrin | 1 | 2009 | 8 | 0.090 |
Why?
|
ABO Blood-Group System | 1 | 2012 | 367 | 0.090 |
Why?
|
Immunologic Memory | 2 | 2017 | 1348 | 0.090 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2012 | 1379 | 0.090 |
Why?
|
Hip Prosthesis | 1 | 2016 | 917 | 0.090 |
Why?
|
Female | 51 | 2017 | 379592 | 0.090 |
Why?
|
Macaca fascicularis | 9 | 2000 | 908 | 0.090 |
Why?
|
Mastocytosis | 1 | 2011 | 160 | 0.090 |
Why?
|
Gene Expression Regulation | 4 | 2014 | 12071 | 0.090 |
Why?
|
Leiomyomatosis | 1 | 2009 | 70 | 0.090 |
Why?
|
Immunosuppressive Agents | 9 | 2014 | 4147 | 0.090 |
Why?
|
Immunoglobulin G | 5 | 2015 | 4554 | 0.080 |
Why?
|
Waldenstrom Macroglobulinemia | 3 | 2005 | 1052 | 0.080 |
Why?
|
Cell Division | 12 | 2009 | 4564 | 0.080 |
Why?
|
DNA-Binding Proteins | 3 | 2013 | 9639 | 0.080 |
Why?
|
Colitis | 2 | 2012 | 1149 | 0.080 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2012 | 491 | 0.080 |
Why?
|
Cytodiagnosis | 1 | 2012 | 435 | 0.080 |
Why?
|
Graft vs Tumor Effect | 1 | 2008 | 72 | 0.080 |
Why?
|
Kidney | 6 | 2014 | 7167 | 0.080 |
Why?
|
Tunica Intima | 1 | 2010 | 464 | 0.080 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 3 | 2003 | 318 | 0.080 |
Why?
|
Adipocytes | 2 | 2012 | 1182 | 0.080 |
Why?
|
Haplotypes | 3 | 2011 | 2781 | 0.080 |
Why?
|
Antibody Specificity | 2 | 2009 | 1094 | 0.080 |
Why?
|
Growth Inhibitors | 3 | 1999 | 385 | 0.070 |
Why?
|
Male | 44 | 2017 | 349538 | 0.070 |
Why?
|
Platelet Count | 1 | 2010 | 780 | 0.070 |
Why?
|
Coloring Agents | 1 | 2009 | 565 | 0.070 |
Why?
|
HIV Infections | 1 | 2013 | 16678 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2003 | 804 | 0.070 |
Why?
|
Congresses as Topic | 1 | 2011 | 764 | 0.070 |
Why?
|
Erythroid Cells | 1 | 2008 | 238 | 0.070 |
Why?
|
Histocompatibility Testing | 5 | 2008 | 742 | 0.070 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2007 | 65 | 0.070 |
Why?
|
Ploidies | 6 | 1996 | 281 | 0.070 |
Why?
|
Stem Cell Transplantation | 2 | 2007 | 1618 | 0.070 |
Why?
|
Chemokines, CC | 2 | 2004 | 291 | 0.070 |
Why?
|
Cell Count | 4 | 2014 | 1831 | 0.070 |
Why?
|
Conjunctival Neoplasms | 1 | 2007 | 79 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 4553 | 0.070 |
Why?
|
Polysaccharides | 1 | 2012 | 1051 | 0.070 |
Why?
|
Vidarabine | 1 | 2007 | 345 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4211 | 0.070 |
Why?
|
Phenotype | 7 | 2017 | 16331 | 0.070 |
Why?
|
Isoenzymes | 3 | 2012 | 1725 | 0.070 |
Why?
|
Membrane Glycoproteins | 5 | 2005 | 3769 | 0.070 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2004 | 766 | 0.070 |
Why?
|
Endothelium, Vascular | 3 | 2010 | 4455 | 0.070 |
Why?
|
Swine | 1 | 2015 | 5934 | 0.070 |
Why?
|
Doxorubicin | 1 | 2012 | 2215 | 0.060 |
Why?
|
Reference Values | 3 | 2010 | 4982 | 0.060 |
Why?
|
Postmenopause | 1 | 2014 | 2461 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2714 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1740 | 0.060 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2016 | 1461 | 0.060 |
Why?
|
Europe | 1 | 2011 | 3339 | 0.060 |
Why?
|
Chorionic Gonadotropin | 1 | 2007 | 474 | 0.060 |
Why?
|
Eye Neoplasms | 1 | 2007 | 313 | 0.060 |
Why?
|
Orbital Neoplasms | 1 | 2007 | 225 | 0.060 |
Why?
|
Erythrocytes | 1 | 2014 | 2452 | 0.060 |
Why?
|
Mice, Knockout | 8 | 2014 | 14554 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2970 | 0.060 |
Why?
|
Immunohistochemistry | 8 | 2017 | 11363 | 0.060 |
Why?
|
Leukemia, T-Cell | 1 | 2004 | 104 | 0.060 |
Why?
|
Megakaryocytes | 1 | 2008 | 542 | 0.060 |
Why?
|
Epithelial Cells | 2 | 2008 | 3678 | 0.060 |
Why?
|
Prognosis | 10 | 2016 | 29010 | 0.060 |
Why?
|
Survival Analysis | 2 | 2016 | 10248 | 0.060 |
Why?
|
Ovary | 1 | 2008 | 981 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2130 | 0.060 |
Why?
|
Leukocytes | 2 | 2005 | 2039 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2014 | 2145 | 0.060 |
Why?
|
Embryonic and Fetal Development | 1 | 2003 | 438 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2015 | 3584 | 0.050 |
Why?
|
Radiation Tolerance | 2 | 1996 | 484 | 0.050 |
Why?
|
L-Selectin | 1 | 2003 | 213 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2014 | 3020 | 0.050 |
Why?
|
Phosphoglycerate Kinase | 1 | 2002 | 68 | 0.050 |
Why?
|
Genes, p53 | 2 | 1995 | 755 | 0.050 |
Why?
|
Granulocytes | 1 | 2004 | 546 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1707 | 0.050 |
Why?
|
Isoantibodies | 2 | 2017 | 680 | 0.050 |
Why?
|
Middle Aged | 31 | 2017 | 213127 | 0.050 |
Why?
|
Tissue Donors | 1 | 2011 | 2205 | 0.050 |
Why?
|
Adult | 29 | 2017 | 213712 | 0.050 |
Why?
|
Antibodies | 2 | 2009 | 2459 | 0.050 |
Why?
|
Cell Movement | 4 | 2003 | 5212 | 0.050 |
Why?
|
Drug Resistance, Multiple | 1 | 2002 | 252 | 0.050 |
Why?
|
Tissue Transplantation | 1 | 2002 | 130 | 0.050 |
Why?
|
Tight Junctions | 1 | 2003 | 310 | 0.050 |
Why?
|
Image Cytometry | 1 | 2001 | 54 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2010 | 14720 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2003 | 341 | 0.050 |
Why?
|
Receptors, CCR5 | 2 | 2003 | 497 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 916 | 0.050 |
Why?
|
Macrophages, Alveolar | 2 | 2000 | 407 | 0.050 |
Why?
|
Bone Marrow Purging | 1 | 2000 | 109 | 0.050 |
Why?
|
Hodgkin Disease | 1 | 2008 | 1413 | 0.050 |
Why?
|
Eosinophils | 2 | 2004 | 953 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2003 | 638 | 0.050 |
Why?
|
Respiratory Mucosa | 1 | 2003 | 427 | 0.050 |
Why?
|
Biopsy | 5 | 2017 | 6756 | 0.050 |
Why?
|
Macrophages | 2 | 2012 | 5655 | 0.050 |
Why?
|
Uterine Neoplasms | 1 | 2009 | 1513 | 0.050 |
Why?
|
Cystadenocarcinoma | 1 | 1999 | 55 | 0.040 |
Why?
|
Germinal Center | 1 | 2003 | 377 | 0.040 |
Why?
|
Mice, Transgenic | 5 | 2014 | 9735 | 0.040 |
Why?
|
DNA Fragmentation | 2 | 1997 | 242 | 0.040 |
Why?
|
HLA-A2 Antigen | 1 | 2000 | 213 | 0.040 |
Why?
|
Leydig Cells | 1 | 1999 | 56 | 0.040 |
Why?
|
Epinephrine | 1 | 2003 | 793 | 0.040 |
Why?
|
Panic Disorder | 1 | 2003 | 616 | 0.040 |
Why?
|
Regeneration | 1 | 2008 | 1485 | 0.040 |
Why?
|
Rats | 7 | 2009 | 24265 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 3 | 1989 | 573 | 0.040 |
Why?
|
Genotype | 2 | 2012 | 12946 | 0.040 |
Why?
|
Mice, Inbred C57BL | 7 | 2012 | 21821 | 0.040 |
Why?
|
Complement C3b | 1 | 1999 | 106 | 0.040 |
Why?
|
Antigens, Differentiation | 3 | 2007 | 926 | 0.040 |
Why?
|
Mitotic Index | 2 | 1996 | 172 | 0.040 |
Why?
|
Complement Membrane Attack Complex | 1 | 1999 | 112 | 0.040 |
Why?
|
Listeriosis | 1 | 2000 | 149 | 0.040 |
Why?
|
Complement C4b | 1 | 1999 | 135 | 0.040 |
Why?
|
Carcinoma, Small Cell | 2 | 1992 | 420 | 0.040 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1967 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5304 | 0.040 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 4 | 2005 | 694 | 0.040 |
Why?
|
Antibodies, Neoplasm | 1 | 2000 | 286 | 0.040 |
Why?
|
Complement C4 | 1 | 1999 | 257 | 0.040 |
Why?
|
Adenoviruses, Human | 1 | 2000 | 257 | 0.040 |
Why?
|
Child, Preschool | 4 | 2017 | 40955 | 0.040 |
Why?
|
Aneuploidy | 5 | 1992 | 530 | 0.040 |
Why?
|
Transcription Factors | 2 | 2011 | 12164 | 0.040 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2017 | 57 | 0.040 |
Why?
|
Cytokines | 1 | 2012 | 7317 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15056 | 0.040 |
Why?
|
Robotics | 1 | 2005 | 892 | 0.040 |
Why?
|
Trachea | 1 | 2003 | 1075 | 0.040 |
Why?
|
Aged | 20 | 2017 | 162944 | 0.040 |
Why?
|
Transplantation Immunology | 2 | 2008 | 547 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2010 | 3455 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 1997 | 69 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1998 | 718 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2003 | 1351 | 0.040 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1999 | 253 | 0.040 |
Why?
|
Receptors, Transforming Growth Factor beta | 3 | 2007 | 314 | 0.040 |
Why?
|
Pneumonia, Bacterial | 1 | 2000 | 316 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3497 | 0.040 |
Why?
|
Lymphocyte Activation | 6 | 2012 | 5519 | 0.040 |
Why?
|
Osteosarcoma | 1 | 2002 | 880 | 0.040 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2015 | 659 | 0.040 |
Why?
|
Frozen Sections | 1 | 2017 | 155 | 0.040 |
Why?
|
Disease Models, Animal | 5 | 2014 | 18006 | 0.040 |
Why?
|
Corrosion | 1 | 2016 | 29 | 0.030 |
Why?
|
B-Lymphocyte Subsets | 1 | 1997 | 246 | 0.030 |
Why?
|
Mice, SCID | 1 | 2002 | 2715 | 0.030 |
Why?
|
Aged, 80 and over | 8 | 2017 | 57683 | 0.030 |
Why?
|
Inhibins | 1 | 1996 | 211 | 0.030 |
Why?
|
S Phase | 2 | 1994 | 423 | 0.030 |
Why?
|
In Situ Hybridization | 3 | 2008 | 1950 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1020 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2000 | 880 | 0.030 |
Why?
|
Graft vs Host Disease | 4 | 2005 | 2951 | 0.030 |
Why?
|
Inflammation | 2 | 2014 | 10578 | 0.030 |
Why?
|
HLA Antigens | 2 | 2017 | 1382 | 0.030 |
Why?
|
Receptors, Fc | 2 | 1989 | 540 | 0.030 |
Why?
|
Lymphocyte Depletion | 3 | 2010 | 608 | 0.030 |
Why?
|
Infant | 3 | 2009 | 35070 | 0.030 |
Why?
|
Chromium | 1 | 2016 | 123 | 0.030 |
Why?
|
Sclerosis | 1 | 2015 | 210 | 0.030 |
Why?
|
Software | 1 | 2009 | 4434 | 0.030 |
Why?
|
Leukemia, Myeloid | 1 | 1998 | 705 | 0.030 |
Why?
|
Ions | 1 | 2016 | 264 | 0.030 |
Why?
|
Melanoma | 4 | 2000 | 5462 | 0.030 |
Why?
|
G2 Phase | 1 | 1995 | 139 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 571 | 0.030 |
Why?
|
Bangladesh | 1 | 2016 | 687 | 0.030 |
Why?
|
Tumor Cells, Cultured | 6 | 2000 | 6313 | 0.030 |
Why?
|
Child | 7 | 2017 | 77478 | 0.030 |
Why?
|
Adenoma | 2 | 1996 | 2168 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2010 | 686 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2010 | 8425 | 0.030 |
Why?
|
Nucleolus Organizer Region | 1 | 1993 | 26 | 0.030 |
Why?
|
Acyltransferases | 1 | 1996 | 294 | 0.030 |
Why?
|
Tonsillectomy | 1 | 2017 | 254 | 0.030 |
Why?
|
Verapamil | 2 | 2006 | 244 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2016 | 401 | 0.030 |
Why?
|
Choroid Plexus Neoplasms | 1 | 1993 | 43 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 1999 | 726 | 0.030 |
Why?
|
Combined Modality Therapy | 6 | 2008 | 8621 | 0.030 |
Why?
|
G1 Phase | 2 | 2012 | 415 | 0.030 |
Why?
|
Clone Cells | 3 | 1999 | 1692 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 749 | 0.030 |
Why?
|
Galectin 4 | 1 | 2012 | 22 | 0.030 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 1991 | 349 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 1995 | 2085 | 0.030 |
Why?
|
Mutation | 3 | 2017 | 29717 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1995 | 358 | 0.030 |
Why?
|
Sarcoma | 2 | 1996 | 1895 | 0.030 |
Why?
|
Immunological Synapses | 1 | 2012 | 54 | 0.030 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 1992 | 63 | 0.030 |
Why?
|
Apoptosis | 3 | 1999 | 9715 | 0.030 |
Why?
|
Luminescent Proteins | 2 | 2007 | 853 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2013 | 193 | 0.030 |
Why?
|
Peptide Fragments | 3 | 2000 | 5095 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3617 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2012 | 2410 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1999 | 1320 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2011 | 2638 | 0.030 |
Why?
|
Cytogenetic Analysis | 1 | 2013 | 295 | 0.030 |
Why?
|
MicroRNAs | 1 | 2008 | 3731 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2018 | 16665 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2014 | 15244 | 0.030 |
Why?
|
Granulosa Cell Tumor | 1 | 1992 | 70 | 0.030 |
Why?
|
Membrane Microdomains | 1 | 2012 | 202 | 0.030 |
Why?
|
Tandem Repeat Sequences | 1 | 2012 | 185 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2003 | 3038 | 0.030 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2012 | 171 | 0.020 |
Why?
|
Immunotherapy | 4 | 2000 | 4414 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 1997 | 1152 | 0.020 |
Why?
|
Biopsy, Needle | 3 | 2001 | 1640 | 0.020 |
Why?
|
Acute Disease | 2 | 1999 | 7141 | 0.020 |
Why?
|
Choroid Plexus | 1 | 1993 | 231 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2014 | 766 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 3 | 1995 | 4029 | 0.020 |
Why?
|
Thoracic Arteries | 1 | 2010 | 41 | 0.020 |
Why?
|
Anthracenes | 1 | 2010 | 84 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6171 | 0.020 |
Why?
|
Green Fluorescent Proteins | 2 | 2008 | 2088 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 12958 | 0.020 |
Why?
|
Caffeine | 1 | 1995 | 699 | 0.020 |
Why?
|
Interferon-gamma | 3 | 2007 | 3199 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2012 | 3701 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2016 | 1203 | 0.020 |
Why?
|
Cell Nucleus | 2 | 1997 | 2968 | 0.020 |
Why?
|
Adenocarcinoma, Follicular | 1 | 1994 | 324 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2015 | 1179 | 0.020 |
Why?
|
Insulinoma | 1 | 1990 | 124 | 0.020 |
Why?
|
Lung Transplantation | 1 | 1999 | 1155 | 0.020 |
Why?
|
Immunologic Factors | 1 | 1999 | 1575 | 0.020 |
Why?
|
Recurrence | 2 | 2015 | 8333 | 0.020 |
Why?
|
Adolescent | 9 | 2017 | 85649 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2007 | 647 | 0.020 |
Why?
|
Vulvar Neoplasms | 1 | 1992 | 272 | 0.020 |
Why?
|
Hypercalcemia | 1 | 1992 | 405 | 0.020 |
Why?
|
Skin Tests | 2 | 1989 | 612 | 0.020 |
Why?
|
Fibrosarcoma | 2 | 1989 | 348 | 0.020 |
Why?
|
Down-Regulation | 2 | 2012 | 3001 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 3 | 1999 | 517 | 0.020 |
Why?
|
Mutagenesis | 1 | 2014 | 1263 | 0.020 |
Why?
|
Antigens, CD7 | 1 | 1989 | 21 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2002 | 2522 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4751 | 0.020 |
Why?
|
Mycosis Fungoides | 1 | 1991 | 163 | 0.020 |
Why?
|
Retrospective Studies | 8 | 2017 | 77098 | 0.020 |
Why?
|
DNA Primers | 1 | 2014 | 2892 | 0.020 |
Why?
|
Polystyrenes | 1 | 2009 | 112 | 0.020 |
Why?
|
Genes, T-Cell Receptor gamma | 1 | 2008 | 15 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 2 | 1992 | 600 | 0.020 |
Why?
|
Androgens | 1 | 1996 | 1271 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2110 | 0.020 |
Why?
|
Soft Tissue Neoplasms | 2 | 1996 | 1361 | 0.020 |
Why?
|
Immunoglobulin M | 2 | 2005 | 1538 | 0.020 |
Why?
|
Genetic Vectors | 2 | 2014 | 3420 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 651 | 0.020 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2008 | 71 | 0.020 |
Why?
|
Biotin | 1 | 2009 | 253 | 0.020 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2008 | 53 | 0.020 |
Why?
|
Lymphocyte Subsets | 2 | 2002 | 315 | 0.020 |
Why?
|
Creatinine | 2 | 2011 | 1916 | 0.020 |
Why?
|
Hemodynamics | 1 | 1999 | 4197 | 0.020 |
Why?
|
Estrous Cycle | 1 | 2008 | 73 | 0.020 |
Why?
|
Cell Survival | 4 | 2002 | 5872 | 0.020 |
Why?
|
Cohort Studies | 2 | 2009 | 40450 | 0.020 |
Why?
|
Diploidy | 3 | 1992 | 138 | 0.020 |
Why?
|
Skin Neoplasms | 3 | 1992 | 5662 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2008 | 78 | 0.020 |
Why?
|
Mice, Mutant Strains | 2 | 2003 | 1866 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2008 | 803 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 1989 | 485 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 1997 | 1899 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8626 | 0.020 |
Why?
|
Treatment Outcome | 8 | 2017 | 62966 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1996 | 1340 | 0.020 |
Why?
|
Integrin beta3 | 1 | 2008 | 122 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2012 | 1227 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2003 | 4229 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 2 | 2009 | 1835 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 2000 | 226 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2019 | 19862 | 0.020 |
Why?
|
Lymph Nodes | 3 | 2008 | 3465 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2000 | 3691 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2008 | 170 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 401 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2924 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2014 | 1025 | 0.020 |
Why?
|
Cadherins | 1 | 2012 | 906 | 0.020 |
Why?
|
Hyperplasia | 1 | 2010 | 1183 | 0.020 |
Why?
|
Remission Induction | 2 | 2005 | 2384 | 0.020 |
Why?
|
Lung Neoplasms | 4 | 1989 | 13019 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 1995 | 2382 | 0.020 |
Why?
|
K562 Cells | 1 | 2008 | 632 | 0.020 |
Why?
|
Kupffer Cells | 1 | 1987 | 142 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1294 | 0.020 |
Why?
|
Granzymes | 1 | 2008 | 270 | 0.020 |
Why?
|
Adoptive Transfer | 2 | 2000 | 844 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2008 | 223 | 0.020 |
Why?
|
Reoperation | 1 | 2016 | 4200 | 0.020 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2007 | 227 | 0.020 |
Why?
|
Hypersensitivity, Immediate | 1 | 1989 | 334 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2005 | 4929 | 0.020 |
Why?
|
Cyclosporins | 3 | 1991 | 220 | 0.020 |
Why?
|
RNA, Messenger | 4 | 2008 | 13029 | 0.020 |
Why?
|
Cyclophosphamide | 2 | 2003 | 2236 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 3 | 2002 | 3770 | 0.020 |
Why?
|
Alcoholism | 1 | 1996 | 1904 | 0.020 |
Why?
|
Phototherapy | 1 | 2008 | 377 | 0.020 |
Why?
|
Patient Care Team | 1 | 2016 | 2527 | 0.020 |
Why?
|
Young Adult | 3 | 2017 | 56350 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40054 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2003 | 7873 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9305 | 0.020 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 1996 | 283 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7716 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1994 | 2940 | 0.020 |
Why?
|
Integrases | 1 | 2007 | 533 | 0.020 |
Why?
|
Developing Countries | 1 | 2016 | 2789 | 0.020 |
Why?
|
Chemokine CCL19 | 1 | 2003 | 35 | 0.020 |
Why?
|
Dexamethasone | 2 | 2003 | 1949 | 0.020 |
Why?
|
Host vs Graft Reaction | 1 | 2003 | 14 | 0.010 |
Why?
|
Chemokine CCL3 | 1 | 2003 | 83 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1989 | 1274 | 0.010 |
Why?
|
Chromosomes | 1 | 1987 | 595 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2008 | 1547 | 0.010 |
Why?
|
Chemokine CCL4 | 1 | 2003 | 128 | 0.010 |
Why?
|
Disease-Free Survival | 2 | 2008 | 6891 | 0.010 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2003 | 122 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2010 | 1504 | 0.010 |
Why?
|
Carcinoma | 2 | 1993 | 2374 | 0.010 |
Why?
|
Erythropoietin | 1 | 2008 | 724 | 0.010 |
Why?
|
Receptors, CCR7 | 1 | 2003 | 108 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 1986 | 675 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2007 | 1799 | 0.010 |
Why?
|
CHO Cells | 1 | 2006 | 1407 | 0.010 |
Why?
|
Fibroblasts | 2 | 2009 | 4143 | 0.010 |
Why?
|
Receptors, KIR | 1 | 2003 | 113 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 1993 | 1155 | 0.010 |
Why?
|
Bone and Bones | 1 | 2014 | 2575 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1997 | 5019 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2003 | 352 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6534 | 0.010 |
Why?
|
Haploidy | 1 | 2003 | 136 | 0.010 |
Why?
|
Binding Sites, Antibody | 2 | 1994 | 349 | 0.010 |
Why?
|
Endometrial Neoplasms | 1 | 1992 | 1351 | 0.010 |
Why?
|
Nitric Oxide | 2 | 2004 | 2128 | 0.010 |
Why?
|
Rats, Inbred Lew | 2 | 2000 | 1161 | 0.010 |
Why?
|
Prostatic Neoplasms | 2 | 1996 | 11039 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 15994 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5180 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2471 | 0.010 |
Why?
|
Kidney Neoplasms | 2 | 1989 | 4229 | 0.010 |
Why?
|
Paraffin Embedding | 2 | 1994 | 299 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2004 | 534 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12242 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2007 | 2123 | 0.010 |
Why?
|
Proteins | 1 | 1997 | 6096 | 0.010 |
Why?
|
Survival Rate | 3 | 2008 | 12773 | 0.010 |
Why?
|
Receptors, Interferon | 1 | 2002 | 115 | 0.010 |
Why?
|
beta Catenin | 1 | 2007 | 1058 | 0.010 |
Why?
|
Dipeptides | 1 | 2003 | 409 | 0.010 |
Why?
|
Radiotherapy | 1 | 2008 | 1525 | 0.010 |
Why?
|
Neutrophils | 1 | 2014 | 3711 | 0.010 |
Why?
|
Kinetics | 2 | 2002 | 6474 | 0.010 |
Why?
|
P-Selectin | 1 | 2004 | 600 | 0.010 |
Why?
|
Stromal Cells | 1 | 2007 | 1353 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2010 | 5163 | 0.010 |
Why?
|
Neoplasm Metastasis | 4 | 1992 | 4839 | 0.010 |
Why?
|
Bone Density | 1 | 2014 | 3469 | 0.010 |
Why?
|
Benzimidazoles | 1 | 2006 | 848 | 0.010 |
Why?
|
HIV-1 | 1 | 1999 | 6934 | 0.010 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2000 | 38 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2004 | 689 | 0.010 |
Why?
|
NAD+ Nucleosidase | 1 | 2000 | 39 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2005 | 2027 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 1994 | 2274 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8436 | 0.010 |
Why?
|
Receptors, Chemokine | 1 | 2003 | 669 | 0.010 |
Why?
|
Recombinant Proteins | 3 | 1999 | 6608 | 0.010 |
Why?
|
gp100 Melanoma Antigen | 1 | 2000 | 39 | 0.010 |
Why?
|
Mitogens | 2 | 1991 | 232 | 0.010 |
Why?
|
MART-1 Antigen | 1 | 2000 | 64 | 0.010 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2000 | 59 | 0.010 |
Why?
|
Enterovirus B, Human | 1 | 2000 | 52 | 0.010 |
Why?
|
Leukocyte Transfusion | 1 | 2000 | 60 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2001 | 587 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2004 | 1262 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2007 | 1613 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2003 | 790 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7790 | 0.010 |
Why?
|
Electric Impedance | 1 | 2003 | 727 | 0.010 |
Why?
|
DNA | 2 | 1999 | 7289 | 0.010 |
Why?
|
Graft vs Leukemia Effect | 1 | 2000 | 109 | 0.010 |
Why?
|
Complement C3 Convertase, Alternative Pathway | 1 | 1999 | 7 | 0.010 |
Why?
|
Electricity | 1 | 2000 | 182 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1992 | 2229 | 0.010 |
Why?
|
Cell Membrane | 2 | 2004 | 3744 | 0.010 |
Why?
|
Gene Library | 1 | 2002 | 1076 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1999 | 171 | 0.010 |
Why?
|
Perfusion | 1 | 2004 | 1359 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2007 | 2006 | 0.010 |
Why?
|
Bone Marrow Examination | 1 | 1999 | 157 | 0.010 |
Why?
|
Transfection | 2 | 1999 | 5892 | 0.010 |
Why?
|
Immunodominant Epitopes | 1 | 2000 | 267 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39004 | 0.010 |
Why?
|
Half-Life | 1 | 2000 | 658 | 0.010 |
Why?
|
Mullerian Ducts | 1 | 1999 | 198 | 0.010 |
Why?
|
Macrophage-1 Antigen | 1 | 1999 | 290 | 0.010 |
Why?
|
Embryo, Mammalian | 2 | 1995 | 1692 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1993 | 5851 | 0.010 |
Why?
|
Histocompatibility | 1 | 2000 | 330 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2001 | 981 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1999 | 449 | 0.010 |
Why?
|
Serotonin | 1 | 2003 | 1024 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2003 | 18112 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1996 | 9185 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2003 | 1213 | 0.010 |
Why?
|
Body Mass Index | 1 | 2016 | 12695 | 0.010 |
Why?
|
Genes, RAG-1 | 1 | 1997 | 68 | 0.010 |
Why?
|
Antilymphocyte Serum | 1 | 2000 | 491 | 0.010 |
Why?
|
Immunoglobulin mu-Chains | 1 | 1997 | 63 | 0.010 |
Why?
|
Virion | 1 | 2000 | 433 | 0.010 |
Why?
|
Mice, Inbred C3H | 2 | 1989 | 964 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1998 | 158 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1998 | 370 | 0.010 |
Why?
|
Chickens | 1 | 1999 | 865 | 0.010 |
Why?
|
Biological Transport | 1 | 2002 | 2119 | 0.010 |
Why?
|
Ascites | 1 | 1999 | 344 | 0.010 |
Why?
|
COS Cells | 1 | 1999 | 1160 | 0.010 |
Why?
|
Poly(A)-Binding Proteins | 1 | 1997 | 36 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1999 | 388 | 0.010 |
Why?
|
Karyotyping | 1 | 1999 | 1243 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 2003 | 1423 | 0.010 |
Why?
|
Activin Receptors | 1 | 1996 | 43 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2003 | 1366 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1999 | 455 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2004 | 3139 | 0.010 |
Why?
|
Cyclosporine | 1 | 2000 | 784 | 0.010 |
Why?
|
Complement Activation | 1 | 1999 | 452 | 0.010 |
Why?
|
Paraproteinemias | 1 | 1999 | 247 | 0.010 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 1999 | 627 | 0.010 |
Why?
|
Models, Chemical | 1 | 1999 | 626 | 0.010 |
Why?
|
Receptors, Virus | 1 | 2000 | 648 | 0.010 |
Why?
|
Tumor Stem Cell Assay | 1 | 1996 | 118 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 2000 | 969 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2077 | 0.010 |
Why?
|
Testis | 1 | 1999 | 800 | 0.010 |
Why?
|
Family | 1 | 2007 | 3144 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 1999 | 8300 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1780 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 1996 | 334 | 0.010 |
Why?
|
Activins | 1 | 1996 | 208 | 0.010 |
Why?
|
Chronic Disease | 2 | 2003 | 9144 | 0.010 |
Why?
|
Signal Transduction | 2 | 2010 | 23387 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 1997 | 455 | 0.010 |
Why?
|
Phytohemagglutinins | 1 | 1994 | 170 | 0.010 |
Why?
|
Idoxuridine | 1 | 1995 | 123 | 0.010 |
Why?
|
Thymus Gland | 1 | 2000 | 1264 | 0.010 |
Why?
|
Paclitaxel | 1 | 2002 | 1707 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9410 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1999 | 1849 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2003 | 2455 | 0.010 |
Why?
|
Immunity, Cellular | 2 | 1992 | 1606 | 0.010 |
Why?
|
X-Rays | 1 | 1995 | 301 | 0.010 |
Why?
|
Silver Staining | 1 | 1993 | 64 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2003 | 6365 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1989 | 3123 | 0.010 |
Why?
|
Mathematics | 1 | 1995 | 727 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1995 | 876 | 0.010 |
Why?
|
Autopsy | 1 | 1977 | 1006 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2007 | 3843 | 0.010 |
Why?
|
Autoantigens | 1 | 1997 | 891 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2003 | 1788 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2000 | 1269 | 0.010 |
Why?
|
Spleen | 1 | 1999 | 2359 | 0.010 |
Why?
|
Models, Animal | 1 | 2000 | 2170 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1990 | 5249 | 0.010 |
Why?
|
Monitoring, Immunologic | 1 | 1993 | 100 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1994 | 1581 | 0.010 |
Why?
|
Immunoglobulin Idiotypes | 1 | 1992 | 201 | 0.010 |
Why?
|
Epitopes | 1 | 1999 | 2569 | 0.010 |
Why?
|
Antibodies, Bispecific | 1 | 1994 | 164 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 4414 | 0.010 |
Why?
|
Fetus | 1 | 1999 | 1879 | 0.010 |
Why?
|
Paraffin | 1 | 1991 | 35 | 0.010 |
Why?
|
Colon | 1 | 2000 | 1773 | 0.010 |
Why?
|
Virus Replication | 1 | 2000 | 2531 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12797 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9581 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3862 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5867 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2002 | 7901 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1992 | 1159 | 0.010 |
Why?
|
Histological Techniques | 1 | 1991 | 198 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2000 | 1889 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1999 | 6382 | 0.010 |
Why?
|
Urethra | 1 | 1992 | 408 | 0.010 |
Why?
|
Genetic Markers | 1 | 1996 | 2633 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 2231 | 0.010 |
Why?
|
Pregnancy | 2 | 2003 | 29087 | 0.010 |
Why?
|
Mitosis | 1 | 1995 | 1208 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 7721 | 0.010 |
Why?
|
Ethanol | 1 | 1996 | 1337 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1989 | 379 | 0.010 |
Why?
|
Glioma | 2 | 1995 | 3388 | 0.010 |
Why?
|
Neurilemmoma | 1 | 1995 | 547 | 0.010 |
Why?
|
Autoantibodies | 1 | 1997 | 2036 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1992 | 1030 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1987 | 6347 | 0.010 |
Why?
|
Actins | 1 | 1997 | 2120 | 0.010 |
Why?
|
Antigens, Fungal | 1 | 1989 | 70 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1991 | 482 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1996 | 20774 | 0.010 |
Why?
|
Lymphokines | 1 | 1991 | 949 | 0.010 |
Why?
|
Mice, Nude | 1 | 1995 | 3689 | 0.000 |
Why?
|
Fatty Acids | 1 | 1996 | 1806 | 0.000 |
Why?
|
United States | 1 | 2015 | 69693 | 0.000 |
Why?
|
Heart Rate | 1 | 1999 | 4091 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13814 | 0.000 |
Why?
|
Radiation Dosage | 1 | 1996 | 1927 | 0.000 |
Why?
|
Centrifugation | 1 | 1987 | 122 | 0.000 |
Why?
|
Peroxidases | 1 | 1987 | 138 | 0.000 |
Why?
|
Heart Diseases | 1 | 2000 | 2789 | 0.000 |
Why?
|
Receptors, IgG | 1 | 1989 | 582 | 0.000 |
Why?
|
Clinical Protocols | 1 | 1992 | 1459 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1990 | 2335 | 0.000 |
Why?
|
Linear Models | 1 | 1996 | 5948 | 0.000 |
Why?
|
Antibody Formation | 1 | 1990 | 1402 | 0.000 |
Why?
|
Immunoglobulins | 1 | 1989 | 880 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2003 | 21719 | 0.000 |
Why?
|
Scattering, Radiation | 1 | 1987 | 498 | 0.000 |
Why?
|
Incidence | 1 | 2003 | 20928 | 0.000 |
Why?
|
Antigens, Viral | 1 | 1989 | 1034 | 0.000 |
Why?
|
Neoplasm Invasiveness | 1 | 1992 | 3612 | 0.000 |
Why?
|
Alcohol Drinking | 1 | 1996 | 3957 | 0.000 |
Why?
|
Blood Pressure | 1 | 1999 | 8541 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1986 | 2645 | 0.000 |
Why?
|
Animals, Newborn | 1 | 1986 | 2723 | 0.000 |
Why?
|
Head and Neck Neoplasms | 1 | 1995 | 2712 | 0.000 |
Why?
|
Glioblastoma | 1 | 1996 | 3456 | 0.000 |
Why?
|
Light | 1 | 1987 | 1374 | 0.000 |
Why?
|
Surgical Procedures, Operative | 1 | 1992 | 1873 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1999 | 25575 | 0.000 |
Why?
|
Neoplasms | 1 | 1988 | 21596 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1992 | 11001 | 0.000 |
Why?
|
Prospective Studies | 2 | 1992 | 53187 | 0.000 |
Why?
|
Colorectal Neoplasms | 1 | 1995 | 6754 | 0.000 |
Why?
|
Age Factors | 1 | 1986 | 18355 | 0.000 |
Why?
|